Ark Biosciences is a clinical stage company focusing on innovative drug discovery and development, especially in the respiratory virus field, for world-wide markets. It is headquartered in the Zhangjiang Hi-tech Park of Shanghai.....
Dr. Jim Wu is founder and CEO of Ark Biosciences. Dr. Wu has an extensive and successful pharma experience in which he contributed to development of antiviral, oncology, metabolic and CNS drugs, including Potiga™/Trobalt™ and Zurampic™ that were approved by FDA and EMEA for global marketing.
Dr. Toovey is an infectious and tropical disease physician and KOL. He has worked in industry and academia, in both developed and developing countries. He advises a number of pharma companies and biotech organizations on infection diseases and drug development from translation research through Phase IV clinical trials
Dr. Yuan has 17 years of preclinical drug development and management experience in multinational pharmaceutical companies. Join Aike 100 before, he is a senior director of Wuxi, R & D project is responsible for a number of international pharmaceutical companies and research institutions of new drugs. Prior to this, he began to study the development of new drugs in AI Erjian on 2000 and delivery system, as the director of the Department of medicinal chemistry researcher led the early drug discovery team, with a number of metabolic and inflammatory diseases used in preclinical candidate molecules. Dr. Yuan is the inventor of more than 30 patents, and is the author of 12 papers and monographs
Ark Biosciences is a clinical stage company focusing on innovative drug discovery and development, especially in the respiratory virus field, for world-wide markets. It is headquartered in the Zhangjiang Hi-tech Park of Shanghai.....
Recruitment：
